Detalhe da pesquisa
1.
Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
BMC Cancer
; 20(1): 821, 2020 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859169
2.
Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.
Blood
; 120(1): 207-13, 2012 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22517898
3.
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.
Blood Cancer J
; 12(11): 151, 2022 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347832
4.
The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated.
Haematologica
; 96(4): 617-20, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21134977
5.
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.
Front Oncol
; 11: 686445, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650910